Literature DB >> 8852333

Aza and diaza bioisosteric anthracene-9,10-diones as antitumor agents.

A P Krapcho1, M J Maresch, M P Hacker, E Menta, A Oliva, F C Giuliani, S Spinelli.   

Abstract

Synthetic routes to aza and diaza bioisosteres related to the anthracene-9,10-dione, mitoxantrone, have been developed. The antitumor properties of these chemotypes are compared with those exhibited by the corresponding carbocyclic analogues. The sensitivity of the expressed cytotoxicities on the position(s) of the nitrogen atom(s) are discussed in terms of potential cellular targets. Several analogues show potential for clinical evaluations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8852333

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  3 in total

Review 1.  Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas.

Authors:  Stefano Volpetti; Francesco Zaja; Renato Fanin
Journal:  Onco Targets Ther       Date:  2014-05-29       Impact factor: 4.147

2.  Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agent.

Authors:  Ben J Evison; Oula C Mansour; Ernesto Menta; Don R Phillips; Suzanne M Cutts
Journal:  Nucleic Acids Res       Date:  2007-05-05       Impact factor: 16.971

3.  Limited efficacy of pixantrone in refractory diffuse large B-cell lymphoma.

Authors:  Aleksander Novakovic; Lucka Boltezar; Barbara Jezersek Novakovic
Journal:  Oncol Lett       Date:  2020-01-10       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.